Skip to main content

Antihyperglycemic and antihyperlipidemic action of Cinnamomi Cassiae (Cinnamon bark) extract in C57BL/Ks db/db mice

Abstract

In previous study, the anti-diabetic effect of Cinnamomi Cassiae extract (Cinnamon bark: Lauraceae) in a type II diabetic animal model (C57BIKsj db/db) has been reported. To explore their mechanism of action, in present study, the effect of cinnamon extract on anti-hyperglycemia and anti-hyperlipidemia was evaluated by measuring the blood glucose levels, serum insulin, and adiponectin levels, serum and hepatic lipids, PPARα mRNA expression in liver and PPARγ mRNA expression in adipose tissue, respectively. Male C57BIKs db/db mice were divided into a diabetic group and cinnamon extract treated group and examined for a period of 12 weeks (200 mg/kg, p.o). The fasting blood glucose and postprandial 2 h blood glucose levels in the cinnamon treated group were significantly lower than those in the control group (p < 0.01), whereas the serum insulin and adiponectin levels were significantly higher in the cinnamon treated group than in the control group (p < 0.05). The serum lipids and hepatic lipids were improved in the cinnamon administered group. Also the PPARα mRNA (liver) and PPARγ mRNA (adipose tissue) expression levels were increased significantly in the cinnamon treated group (p < 0.05). Our results suggest that cinnamon extract significantly increases insulin sensitivity, reduces serum, and hepatic lipids, and improves hyperglycemia and hyperlipidemia possibly by regulating the PPAR-medicated glucose and lipid metabolism.

This is a preview of subscription content, access via your institution.

References

  • Chou, C. J., Haluzik, M., Gregory, C., Dietz, K. R., Vinson, C., Gavrilova, O., and Reitman, M. L., WY14, 643, a peroxisome proliferator-activated receptor alpha (PPARalpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice. J. Biol. Chem., 227, 24484–24489 (2002).

    Article  CAS  Google Scholar 

  • Etgen, G. J., Oldham, B. A., Johnson, W. T., Broderick, C. L., Montrose, C. R., Brozinick, J. T., Misener, E. A., Bean, J. S., Bensch, W. R., Brooks, D. A., Shuker, A. J., Rito, C. J., Mccarthy, J. R., Ardecky, R. J., Tyhonas, J. S., Dana, S. L., Bilakovics, J. M., Patemiti, J. R., Ogilivie, K. M., Liu, S., and Kauffman, R. F., A tailored therapy for the metabolic syndrome: the dual peroxisome proliferators — activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models. Diabetes, 51, 1083–1087 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Folch, J., Lees, M., and Sloane Stanley, G. H., A simple method for the isolation and purification of total lipids from animal tissue, J. Biol. Chem., 226, 497–509 (1957).

    PubMed  CAS  Google Scholar 

  • Frias, J. P., Yu, J. G., Kruszynska, Y. T., and Olefsky, J. M., Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects. Diabetes Care, 23, 64–69 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Fruebis, J., Tsao, T. S., Javorschi, S., Ebbets-Reed, D., Erickson, M. R., Yen, F. T., Bihain, B. E., and Lodish, H. F., Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U S A., 98, 2005–2010 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Gesler, W. W., Therapeutic landscapes: medical issues in light of the new cultural Geography. Soc. Sci. Med., 34, 735–746 (1992).

    Article  PubMed  CAS  Google Scholar 

  • Guo, Q., Sahoo, S. P., Wang, P. R., Milot, D. P., Ippolito, M. C., Wu, M. S., Baffic, J., Biswas, C., Hernandez, M., Lam, M. H., Sharma, N., Han, W., Kelly, L. J., MacNaul, K. L., Zhou, G. Desai, R., Heck, J. V., Doebber, T. W., Berger, J. P., Moller, D. E., Sparrow, C. P., Chao, Y. S., and Wright, S. D., A Novel Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist Demonstrates Favorable Effects on Lipid Homeostasis. Endocrinology, 145, 1640–1648 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Haban, P., Simoncic, R., Zidekova, E., and Ozdin, L., Role of fasting serum C-peptide as a predictor of cardiovascular risk associated with the metabolic X-syndrome. Med. Sci. Monit., 8, 175–179 (2002).

    Google Scholar 

  • Herz, M., Johns, D., Reviriego, J., Grossman, L. D., Godin, C., Duran, S., Hawkins F., Lochnan, H., Escobar-jimenez, F., Hardin, P. A., Konkoy, C. S., and Tan, M. H., A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus. Clin. Ther., 25, 1074–1095 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Hsueh, W. A. and Law, R., The central role of fat and effect of peroxisome proliferator activated receptor-gamma on progression of insulin resistance and cardiovascular disease. Am. J. Cardiol., 92, 3J–9J (2003).

    Article  PubMed  CAS  Google Scholar 

  • Jackson, S. M., Parhami, F., Xi, X. P., Berliner, J. A., Hsueh, W. A., Law, R. E., and Demer, L. L., Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction, Arterioscler. Thromb. Vasc. Biol., 19, 2094–2104 (1999).

    PubMed  CAS  Google Scholar 

  • Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., and Wahli, W., Peroxisome proliferatoractivated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest., 103, 1489–1498 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Kim, H., Haluzik, M., Asghar, Z., Yau, D., Joseph, J. W., Fernandez, A. M., Reitman, M. L., Yakar, S., Stannard, B., Heron-Milhavet, M. B., and Wheeler, D., Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverse the lipotoxic state and improves glucose homeostasis. Diabetes, 52, 1770–1778 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Kimura, S., Tomita, M., Froguel, P., and Kadowoki, T., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med., 7, 941–946 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Kintscher, U. and Law, R. E., PPARgamma-mediated insulin sensitization: the importance of fat versus muscle. Am. J. Physiol. Endocrinol. Metab., 288, 287–291 (2005).

    Article  CAS  Google Scholar 

  • Kitahara, Y., Miura, K., Takesue, K., Mine, T., Wada, R., Uchida, Y., lto, S., and Yagihashi, S., Decreased blood glucose excursion by nateglinide ameliorated neuropathic changes in Goto-Kakizaki rats, an animal model of nonobese type 2 diabetes, Metabolism, 51, 1452–1457 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., Satoh, S., Nakano, R., Ishii, C., Sugiyama, T., Eto, K., Tsubamoto, Y., Okuno, A., Murakami, K., Sekihara, H., Hasegawa, G., Naito, M., Toyoshima, Y., Tanaka, S., Shiota, K., Kitamura, T., Fujta, T., Ezaki, O., Aizawa, S., and Kadowaki, T., PPARgamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell, 4, 597–609 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Lee, C. H., Olson, P., and Evans, R. M., Mini review: lipid metabolism, metabolic diseases, and peroxisome proliferators-activated receptors. Endocrinology, 144, 2201–2207 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., Kuriyama, H., Hotta, K., Nakamura, T., Shimomura, I., and Matsuzawa, Y., PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes, 50, 2094–2099 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Miyazaki, Y., Mahankli, A., Matsuda, M., Glass, L., Mahankali, S., Ferrannini, E., Cusi, K., Mandarino, L. J., and DeFronzo, R. A., Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone. Diabetes Care, 24, 710–719 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Nolan, J. J., Ludvik, B., Beerdsen, P., Joyce, M., and Olefsky, J., Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N. Engl. J. Med., 331, 1188–1193 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Raskin, P., Rappaport, E. B., Cole, S. T., Yan, Y., Patwardhan, R., and Freed, M. I., Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type diabetes. Diabetologia, 43, 278–284 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Reddy, J. K. and Hashimoto, T., Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu. Rev. Nutr., 21, 193–230 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Ryan, A. S., Berman, D. M., Nicklas, B. J., Sinba, M., Gingerich, R. L., Meneilly, G. S., Egan, J. M., and Elahi, D., Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care, 26, 2383–2388 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Schoonjans, K., Watanabe, M., Suzuki, H., Mahfoudi, A., Krey, G., Wahli, W., Grimaldi, P., Staels, B., Yamamoto, T., and Auwerx, J., Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferators response element in the C promoter. J. Biol. Chem., 270, 19269–19276 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Spratt, K. A., A clinician’s guide to a woman’s heart. J. Am. Osteopath. Assoc., 98, 1–6 (1998).

    Google Scholar 

  • Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., and Fruchart, J. C., Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation, 98, 2088–2093 (1998).

    PubMed  CAS  Google Scholar 

  • Sugden, M. C. and Holness, M. J., Potential role of peroxisome proliferator-activated activated receptor-alpha in the modulation of glucose-stimulated insulin secretion. Diabetes, 53, S71–S81 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Tontonoz, P., Hu, E., and Spiegelman, B. M., Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipidactivated transcription factor. Cell, 79, 1147–1156 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Vidal-Puig, A. J., Considine, R. V., Jimenez-Linan, M., Werman, A., Pories, W. J., Caro, J. F., and Flier, J. S., Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J. Clin. Invest., 99, 2416–2422 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Yamauchi, T., Kamon, J., Waki, H., Murakami, K., Motojima, K., Komeda, K., Ide, T., Kubota, N., Terauchi, Y., Tobe, K., Miki, H., Tsuchida, A., Akanuma, Y., Nagai, R., Kimura, S., and Kadowaki, T., The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPAR gamma) deficiency and PPAR gamma agonist improve insulin resistance. J. Biol. Chem., 276, 41245–41254 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Yang, W. S., Lee, W. J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C. L., Chen, C. L., Tai, T. Y., and Chuang, L. M., Weight reducation increases plasma levels of an adiposederived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol. Metab., 86, 3815–3819 (2001).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Se Young Choung.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kim, S.H., Choung, S.Y. Antihyperglycemic and antihyperlipidemic action of Cinnamomi Cassiae (Cinnamon bark) extract in C57BL/Ks db/db mice. Arch. Pharm. Res. 33, 325–333 (2010). https://doi.org/10.1007/s12272-010-0219-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-010-0219-0

Key words

  • Cinnamomi Cassia
  • Anti-hyperglycemia
  • Anti-hyperlipidemia
  • Adiponectin
  • PPARα
  • PPARγ